Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News EQS Group poised to acquire Data Legal Drive to strengthen European compliance SaaS leadership EQS Group, a preeminent international cloud software provider specializing in corporate compliance, investor relations, and sustainability reporting, announced… byPallavi MadhirajuJuly 6, 2024